Advances in Managing NTRK Fusion-Positive CNS Cancers Available Diagnostic Assays to Identify Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusions in Primary Central Nervous System (CNS) Tumors

Advances in Managing NTRK Fusion-Positive CNS Cancers Available Diagnostic Assays to Identify Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusions in Primary Central Nervous System (CNS) Tumors is organized by Projects In Knowledge Inc. (PIK).

Release Date: Jun 01, 2023
Termination Date: May 31, 2024

Activity Goal:
The goal of this activity is to provide the most current clinical information and practical management strategies in treating CNS tumors, as seen in clinical practice, in a customized, interactive, and easily digestible on-demand educational program.

Learning Objective(s):
• Describe key characteristics of available diagnostic assays, including tissue next-generation sequencing, to guide subsequent treatment selection for primary central nervous system cancers.

Additional details will be posted as soon as information is available.

0.5 MOC | 0.5 IPCE | 0.5 AMA PRA Category 1 Credit™ | 0.5 Contact Hours | 0.1 CEU